Injectafer is the brand name for ferric carboxymaltose, an intravenous iron replacement therapy. It’s a medication given directly into a vein (IV) to treat iron deficiency anemia (IDA), particularly in situations where oral iron supplements are ineffective or cannot be used. Injectafer delivers iron in a form that the body can use to make new red blood cells, thereby increasing hemoglobin levels and improving symptoms of anemia such as fatigue and weakness. It was first approved by the FDA in 2013 and has since become a commonly used IV iron option for patients with significant iron deficiency.
Who Needs Injectafer?
Injectafer is indicated for adults and children (1 year and older) with iron deficiency anemia who either cannot tolerate oral iron or did not respond well to it, and for adults with iron deficiency anemia associated with non-dialysis dependent chronic kidney disease. Many patients start with oral iron pills (like ferrous sulfate), but oral iron can cause side effects (like stomach upset or constipation) and sometimes doesn’t adequately raise iron levels. In such cases, a doctor may prescribe Injectafer to replenish iron more effectively. Additionally, Injectafer is approved to treat iron deficiency in adult patients with heart failure (NYHA class II/III) in order to improve their exercise capacity. In heart failure, treating iron deficiency (even if the person isn’t severely anemic) can lead to better energy and endurance, and Injectafer is one of the therapies that can address that iron deficiency quickly.
Some real-world examples of who might get Injectafer include:
- A person with chronic iron deficiency anemia from heavy menstrual bleeding or gastrointestinal bleeding who hasn’t improved with oral iron.
- A patient with chronic kidney disease not yet on dialysis, where anemia is common and oral iron may not be sufficient.
- Someone with inflammatory bowel disease (Crohn’s, ulcerative colitis) who cannot absorb iron well through the gut or cannot tolerate oral iron’s GI side effects.
- A heart failure patient with low iron stores (even without severe anemia) to help improve their symptoms and exercise tolerance.
In essence, if a patient’s iron deficiency anemia is significant and especially if time is of the essence to correct it (for instance, pre-surgery, during pregnancy, or due to symptomatic anemia), IV iron like Injectafer can rapidly replete iron stores.
Size: 750 mg iron / 15 mL single-use vial
NDC: 00517-0650-02
UPC: 305170650025
Injectafer is a prescription IV iron therapy used to rapidly and effectively treat iron deficiency anemia in appropriate patients. It bypasses the absorption issues of oral iron by delivering iron directly into the bloodstream.. A typical treatment involves one or two infusions to provide a full iron repletion (~1500 mg total). Patients receiving Injectafer are monitored for safety during administration, as IV iron – while generally safe – can have infrequent serious reactions and some mild side effects like nausea or headache. For those who cannot use oral iron or need a faster response, Injectafer can significantly improve iron levels, increase red blood cell production, and alleviate the symptoms of anemia, helping patients regain energy and quality of life.
How Injectafer Is Given
Injectafer is administered under the supervision of a healthcare provider, usually at an infusion center, clinic, or hospital setting. It comes in vials as a dark brown, sterile solution containing iron at a concentration of 50 mg per mL. The dosing is often described in terms of elemental iron. A typical course for an adult is a total of 1500 mg of iron, given in two separate doses of 750 mg at least 7 days apart. In practical terms, this might mean an IV infusion (or IV push) of one 750 mg dose, then about a week later the second 750 mg dose, to cumulatively replace 1500 mg of iron. This two-dose regimen is one of Injectafer’s distinguishing features – it allows a large amount of iron to be given over just 1 or 2 sessions, whereas some older IV iron products required 5-10 smaller infusions to get a similar total dose.
For patients with lower body weight (under 50 kg, about 110 lbs), or in pediatric cases, the dose is adjusted to 15 mg per kg body weight, also split into two sessions a week apart. There’s also an option for a single 1000 mg dose for certain adult patients (15 mg/kg up to 1000 mg in one go) if the doctor deems it appropriate), but most often the two-dose approach is used to maximize total iron delivered (since 1500 mg total can be given that way).
The medication can be given as a slow IV push or more commonly diluted into a saline bag and given as an IV drip (infusion) over a period (usually around 15 minutes or so, depending on the dose and facility protocol). This controlled administration allows monitoring during the infusion for any reactions. Injectafer is a dark, amber-colored solution when prepared, and it may temporarily tint the IV tubing or the patient’s urine a darker color – that’s normal due to the iron content. Because it’s given IV, 100% of the iron goes directly into the bloodstream, bypassing the absorption limitations of the gut. This means it can quickly raise iron levels in the body – a big advantage when oral iron isn’t enough.
One important point: Injectafer (and IV irons in general) are not blood transfusions and do not provide red blood cells directly. Instead, they provide the raw material (iron) needed for your body to make its own red blood cells over days and weeks. Patients shouldn’t expect an instantaneous hemoglobin jump the next day; rather, over 2-4 weeks after the infusion, the bone marrow uses that iron to produce more red cells, and hemoglobin typically rises. Many patients, however, report improvement in symptoms (like fatigue or restless legs) within days to a week as iron stores replenish even before the hemoglobin fully recovers.
Benefits of IV Iron (Injectafer) vs Oral Iron
Oral iron supplements (pills or liquid taken by mouth) are often the first-line treatment for mild to moderate iron deficiency. However, oral iron has limits: the body can only absorb a small fraction (often <10% of the iron from oral doses) and many patients experience gastrointestinal side effects (constipation, nausea, black stools). It can take months of daily oral iron to replete iron stores, and some people simply can’t stick with it or don’t absorb it well due to gastric issues or ongoing blood loss.
Injectafer, as an IV iron, ensures 100% absorption because the iron is delivered directly into circulation. It also allows much larger doses of iron in a short time: for example, 1500 mg over a week or two, which would be impossible to achieve with oral iron in that timeframe. For someone who is significantly anemic (say hemoglobin far below normal) or symptomatic, this can make a noticeable difference in how quickly they recover. Injectafer has been shown in clinical trials to effectively raise hemoglobin and iron stores with just those one or two infusions for most patients, whereas oral iron might require daily therapy for 3-6 months. Additionally, because the iron is bound in a carboxymaltose sugar complex, it’s released in a controlled fashion from the bloodstream to iron-binding proteins, making it generally well-tolerated.
Another scenario is patients who simply cannot take oral iron due to intolerance (severe GI upset) or malabsorption (e.g., prior gastric bypass surgery which impairs iron absorption, or inflammatory bowel disease where oral iron worsens gut inflammation). For them, IV iron like Injectafer isn’t just faster – it may be the only effective option to correct the anemia.
Injectafer Side Effects
As with any IV iron product, there are some important safety considerations with Injectafer:
-
Allergic Reactions: Although rare, intravenous iron can cause serious hypersensitivity reactions (including anaphylaxis in very rare cases). Patients are usually monitored during the infusion and for at least 30 minutes afterwards for any signs of allergy. Signs of a reaction can include hives, difficulty breathing, dizziness or feeling faint, swelling of the face or throat, or chest tightness. Medical staff will have emergency medications on hand (like epinephrine) just in case. It’s worth noting that older IV irons (like iron dextran) had higher allergic risk; ferric carboxymaltose (Injectafer) has a lower risk, but vigilance is still standard. If you have a known allergy to Injectafer specifically or any of its components, of course it should not be used.
-
High Blood Pressure: Some people experience a temporary spike in blood pressure during or after the infusion. This might manifest as a headache, flushing (warmth and redness), dizziness, or a feeling of pounding in the ears. These usually resolve on their own, but healthcare providers will monitor blood pressure during and post-infusion. If someone already has labile hypertension, they’ll be watched closely.
-
Low Phosphate Levels (Hypophosphatemia): A known side effect of Injectafer (ferric carboxymaltose) is that it can cause phosphate levels in the blood to drop in some patients. For most people this is mild and without symptoms, but in some cases (especially after repeated doses) it could lead to muscle weakness, fatigue, or bone pain if phosphate becomes very low. In rare instances, it has led to osteomalacia (softening of bones) when untreated. Doctors may check blood phosphate if you’re getting multiple courses of Injectafer or have risk factors for low phosphate. Ensuring a balanced diet or supplements might be advised if levels drop.
-
Injection/Infusion Reactions: Aside from allergy, patients can have minor infusion-related effects like nausea or dizziness (these are among the most common side effects, each occurring in a few percent of patients). Headache or flushing are also reported commonly. Some people might feel a bit lightheaded or tired after the infusion, so you may be asked to stay hydrated and possibly remain at the clinic for a short observation period. There can also be local reactions such as pain, bruising, or discoloration at the IV site if any of the iron leaks outside the vein (known as extravasation). The staff take care to inject it properly, but if you feel burning or severe pain at the IV site, alert them – they’ll check to ensure the IV is still in the vein well.
-
Iron Overload: Injectafer should not be given to people with iron overload conditions (like hemochromatosis) or anemia that isn’t due to iron deficiency (for example, anemia of chronic disease without iron deficiency). Before starting therapy, typically the doctor will do blood tests (iron levels, transferrin saturation, ferritin) to confirm that you are truly iron-deficient. Getting too much iron can deposit in organs and cause damage, so the treatment is carefully matched to the degree of deficiency. That said, the dosing schedules are designed so that for most patients, one course restores iron to normal – if more is needed, they will check levels and not just give endless iron without monitoring. Signs of having too much iron (iron overload) after treatment could include joint pain, fatigue, heart rhythm changes or liver issues, but these are unlikely if the medication is used appropriately.
-
Other Side Effects: In clinical trials, other side effects that occurred in some patients include rash, itching, or mild transient changes in lab tests (like liver enzymes). Many people actually feel significantly better a week or two after Injectafer as their anemia improves, despite maybe having a day or two of minor side effects right after the infusion (like headache or nausea). If you’ve had any reaction to other IV irons in the past, let your doctor know, as that might influence the choice of product or premedication.
